THURSDAY, July 5 (HealthDay News) — The first DNA test to help doctors treat a common viral infection in people who have had a solid organ transplant has been approved by the U.S. Food and Drug Administration.
THURSDAY, July 5 (HealthDay News) — Heart failure patients who are carrying extra pounds have a lower risk of death and other heart failure-related health outcomes than thin or normal-weight patients, new research suggests.
NIH-funded study finds more precise way to estimate kidney functionPharmaceutical ProcessingMeasuring creatinine and cystatin C — two markers for chronic kidney disease (CKD) — more precisely estimates kidney function than either marker alone, accord…
FDA Approves Roche Test to Track Progress Treating Common Infection in Organ Transplant Patients
The U.S. Food and Drug Administration today approved the first DNA test to help health care professionals gauge the progress of anti-viral treatment in solid organ transplant patients undergoing cytomegalovirus (CMV) antiviral therapy.
India, China leaders in innovation despite lack of resourcesmydigitalfc.comResources may be scarce but Indians and Chinese don't seem to lose heart so far as innovation is concerned. The dearth of facilities is only pushing them ahead.and more …
JGH offers free classes on Congestive Heart Failure, Managing Diabetes July 16Jackson County NewspapersOn Wednesday, July 16 Jackson General Hospital will have two classes, one on Congestive Heart Failure at 1 p.m. and Managing diabetes at 9 a.m..
NEWS 8 EXCLUSIVE DALLAS – A transplant patient at Methodist Dallas Medical Center was mistakenly given a kidney, last week, though that patient was not next in line, the hospital says. As result, Methodist confirms, it has voluntarily suspended its k…
MediplacementsObese Heart Failure Patients Have Better OutcomesMedical News TodayAdvanced heart failure patients are considerably less likely to experience adverse outcomes if they are obese and have a higher waist circumference, according to UCLA rese…
(Reuters) – U.S. health regulators on Thursday approved a first-of-its-kind DNA test by Swiss drugmaker Roche Holding AG to help physicians track progress in treating organ transplant patients for a common virus. Roche's COBAS AmpliPrep/COBAS TaqMa…